Bradley
Schlaggar
,
MD, PhD
707 N Broadway
Baltimore, MD 21205
United States
About Our President and CEO
Dr. Bradley Schlaggar is the president and CEO of Kennedy Krieger Institute and holds the Zanvyl Krieger Faculty Endowed Chair at Kennedy Krieger. He is also a professor of neurology and pediatrics at The Johns Hopkins University School of Medicine. At the Institute, Dr. Schlaggar leads a team of nearly 3,500 full and part-time staff and faculty members to advance the organization’s longstanding mission of improving the lives of children, adolescents and young adults with, and those at risk of, disorders and injuries of the brain, spinal cord and musculoskeletal system.
Education
Before joining Kennedy Krieger in 2018, Dr. Schlaggar served on the staff and faculty of the Washington University School of Medicine in St. Louis for 19 years, including four years (2014-2018) as the division head of pediatric and developmental neurology, co-director of the Intellectual and Developmental Disabilities Research Center and neurologist-in-chief at St. Louis Children’s Hospital.
Dr. Schlaggar earned a Bachelor of Science degree with honors from Brown University, and Doctor of Medicine and Doctor of Philosophy degrees from the Washington University School of Medicine in St. Louis. In 1999, he completed his pediatric neurology residency training at St. Louis Children's Hospital and Washington University, where he served as the pediatric neurology residency director from 2005 to 2013, before becoming head of pediatric and developmental neurology at the school of medicine.
Dr. Schlaggar’s clinical expertise in pediatric neurology is in disorders of movement, language, and cognition.
He is a highly sought-after lecturer. He has published over 200 research papers and is recognized as a highly-cited (i.e., in the top one percent) investigator. He is a co-founder of the Flux Society for Developmental Cognitive Neuroscience. He has been recognized with numerous awards for research, mentorship, clinical care and community service, including the Philip R. Dodge Young Investigator Award from the Child Neurology Society (2003), the Norman Geschwind Award for Behavioral Neurology from the American Academy of Neurology (2009), the E. Mead Johnson Award from the Society for Pediatric Research (2012), the Frank Hatch Award for Outstanding Community Service from the John Merck Foundation (2014), and the Huttenlocher Lifetime Achievement Award from the Flux Society for Developmental Cognitive Neuroscience (2024). In 2021, he was elected to the Academy of American Physicians. He was recognized by the Baltimore Area Council of Scouting America with the 2024 Health Services Leadership Award. The World Trade Center Institute awarded Dr. Schlaggar with a 2026 Maryland International Business Leadership Award. Maryland’s The Daily Record has recognized him as a Most Admired CEO (2022) and a member of the Health Care Power List (2023, 2024).
Research
Dr. Schlaggar's research efforts, funded primarily by the National Institutes of Health, have been directed at understanding the development of the brain's functional network architecture in typically- and atypically-developing children.